Alnylam Pharmaceuticals (ALNY) Equity Ratio (2009 - 2026)
Alnylam Pharmaceuticals posted quarterly Equity Ratio of 0.21 for Q1 2026, up 107.3% year-on-year from 0.1 in Q1 2025, and up 31.93% on a QoQ basis from 0.16 in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 18 years of Equity Ratio data on file, last reported at 0.21 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio rose 107.3% year-over-year to 0.21; the trailing twelve-month figure through Mar 2026 stood at 0.21 (up 107.3% YoY), and the FY2025 full-year result was 0.16, up 904.29% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.21, up from 0.16 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.21 in Q1 2026 and bottomed at 0.12 in Q2 2023.
- The 5-year median for Equity Ratio is 0.01 (2024), against an average of 0.02.
- The widest annual swing landed in 2023, when Equity Ratio tumbled 326.94%; it then surged 7274.95% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.04 in 2022, then fell by 29.13% to 0.06 in 2023, then jumped by 127.46% to 0.02 in 2024, then soared by 904.29% to 0.16 in 2025, then surged by 31.93% to 0.21 in 2026.
- The last three Equity Ratio figures came in at 0.21 (Q1 2026), 0.16 (Q4 2025), and 0.05 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 0.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.21 |
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.05 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.12 |
| Mar 31, 2023 | -0.08 |
| Dec 31, 2022 | -0.04 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.16 |
| Sep 30, 2021 | 0.22 |
| Jun 30, 2021 | 0.24 |
| Mar 31, 2021 | 0.28 |
| Dec 31, 2020 | 0.30 |
| Sep 30, 2020 | 0.37 |
| Jun 30, 2020 | 0.41 |
| Mar 31, 2020 | 0.59 |
| Dec 31, 2019 | 0.60 |
| Sep 30, 2019 | 0.63 |
| Jun 30, 2019 | 0.65 |
| Mar 31, 2019 | 0.77 |
| Dec 31, 2018 | 0.83 |
| Sep 30, 2018 | 0.88 |
| Jun 30, 2018 | 0.91 |
| Mar 31, 2018 | 0.91 |
| Dec 31, 2017 | 0.89 |
| Sep 30, 2017 | 0.78 |
| Jun 30, 2017 | 0.78 |
| Mar 31, 2017 | 0.73 |
| Dec 31, 2016 | 0.73 |
| Sep 30, 2016 | 0.77 |
| Jun 30, 2016 | 0.79 |
| Mar 31, 2016 | 0.90 |
| Dec 31, 2015 | 0.91 |
| Sep 30, 2015 | 0.92 |
| Jun 30, 2015 | 0.92 |
| Mar 31, 2015 | 0.92 |
| Dec 31, 2014 | 0.87 |
| Sep 30, 2014 | 0.92 |
| Jun 30, 2014 | 0.91 |
| Mar 31, 2014 | 0.88 |
| Dec 31, 2013 | 0.64 |
| Sep 30, 2013 | 0.66 |
| Jun 30, 2013 | 0.67 |
| Mar 31, 2013 | 0.66 |
| Dec 31, 2012 | 0.47 |
| Sep 30, 2012 | 0.55 |
| Jun 30, 2012 | 0.59 |
| Mar 31, 2012 | 0.58 |
| Dec 31, 2011 | 0.42 |
| Sep 30, 2011 | 0.41 |
| Jun 30, 2011 | 0.40 |
| Mar 31, 2011 | 0.39 |
| Dec 31, 2010 | 0.40 |
| Sep 30, 2010 | 0.39 |
| Jun 30, 2010 | 0.38 |
| Dec 31, 2009 | 0.37 |